位置:首页 > 蛋白库 > NUD16_HUMAN
NUD16_HUMAN
ID   NUD16_HUMAN             Reviewed;         195 AA.
AC   Q96DE0; B4E3B4; E9PED4; F5GYJ1; Q96N82;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 2.
DT   03-AUG-2022, entry version 163.
DE   RecName: Full=U8 snoRNA-decapping enzyme;
DE            EC=3.6.1.62 {ECO:0000269|PubMed:15053875, ECO:0000269|PubMed:17567574, ECO:0000269|PubMed:18820299, ECO:0000269|PubMed:21070968, ECO:0000269|PubMed:21337011};
DE   AltName: Full=IDP phosphatase;
DE            Short=IDPase;
DE            EC=3.6.1.64 {ECO:0000269|PubMed:20385596, ECO:0000269|PubMed:26121039};
DE   AltName: Full=Inosine diphosphate phosphatase;
DE   AltName: Full=Nucleoside diphosphate-linked moiety X motif 16;
DE            Short=Nudix motif 16;
DE   AltName: Full=Nudix hydrolase 16;
DE   AltName: Full=U8 snoRNA-binding protein H29K {ECO:0000303|PubMed:17567574};
DE   AltName: Full=m7GpppN-mRNA hydrolase;
GN   Name=NUDT16;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 21-195 (ISOFORM 1).
RC   TISSUE=Kidney, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=16344560; DOI=10.1101/gr.4039406;
RA   Kimura K., Wakamatsu A., Suzuki Y., Ota T., Nishikawa T., Yamashita R.,
RA   Yamamoto J., Sekine M., Tsuritani K., Wakaguri H., Ishii S., Sugiyama T.,
RA   Saito K., Isono Y., Irie R., Kushida N., Yoneyama T., Otsuka R., Kanda K.,
RA   Yokoi T., Kondo H., Wagatsuma M., Murakawa K., Ishida S., Ishibashi T.,
RA   Takahashi-Fujii A., Tanase T., Nagai K., Kikuchi H., Nakai K., Isogai T.,
RA   Sugano S.;
RT   "Diversification of transcriptional modulation: large-scale identification
RT   and characterization of putative alternative promoters of human genes.";
RL   Genome Res. 16:55-65(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION AS A DECAPPING ENZYME, AND CATALYTIC ACTIVITY.
RX   PubMed=15053875; DOI=10.1016/s1097-2765(04)00127-3;
RA   Ghosh T., Peterson B., Tomasevic N., Peculis B.A.;
RT   "Xenopus U8 snoRNA binding protein is a conserved nuclear decapping
RT   enzyme.";
RL   Mol. Cell 13:817-828(2004).
RN   [6]
RP   FUNCTION AS A DECAPPING ENZYME, SUBUNIT, CATALYTIC ACTIVITY, AND COFACTOR.
RX   PubMed=17567574; DOI=10.1074/jbc.m704179200;
RA   Peculis B.A., Reynolds K., Cleland M.;
RT   "Metal determines efficiency and substrate specificity of the nuclear NUDIX
RT   decapping proteins X29 and H29K (Nudt16).";
RL   J. Biol. Chem. 282:24792-24805(2007).
RN   [7]
RP   FUNCTION AS A DECAPPING ENZYME, CATALYTIC ACTIVITY, SUBUNIT, RNA-BINDING,
RP   GENE EVOLUTION, AND GENE FAMILY ORGANIZATION.
RX   PubMed=18820299; DOI=10.1093/nar/gkn605;
RA   Taylor M.J., Peculis B.A.;
RT   "Evolutionary conservation supports ancient origin for Nudt16, a nuclear-
RT   localized, RNA-binding, RNA-decapping enzyme.";
RL   Nucleic Acids Res. 36:6021-6034(2008).
RN   [8]
RP   FUNCTION AS A DECAPPING ENZYME, CATALYTIC ACTIVITY, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=21070968; DOI=10.1016/j.molcel.2010.10.010;
RA   Song M.G., Li Y., Kiledjian M.;
RT   "Multiple mRNA decapping enzymes in mammalian cells.";
RL   Mol. Cell 40:423-432(2010).
RN   [9]
RP   FUNCTION AS AN IDP PHOSPHATASE, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=20385596; DOI=10.1093/nar/gkq249;
RA   Iyama T., Abolhassani N., Tsuchimoto D., Nonaka M., Nakabeppu Y.;
RT   "NUDT16 is a (deoxy)inosine diphosphatase, and its deficiency induces
RT   accumulation of single-strand breaks in nuclear DNA and growth arrest.";
RL   Nucleic Acids Res. 38:4834-4843(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   FUNCTION AS A DECAPPING ENZYME, CATALYTIC ACTIVITY, COFACTOR, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=21337011; DOI=10.1007/s13238-011-1009-2;
RA   Lu G., Zhang J., Li Y., Li Z., Zhang N., Xu X., Wang T., Guan Z., Gao G.F.,
RA   Yan J.;
RT   "hNUDT16: a universal decapping enzyme for small nucleolar RNA and
RT   cytoplasmic mRNA.";
RL   Protein Cell 2:64-73(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS).
RX   PubMed=18607096; DOI=10.1107/s1744309108016928;
RA   Zhang J., Gao F., Zhang Q., Chen Q., Qi J., Yan J.;
RT   "Crystallization and crystallographic analysis of human NUDT16.";
RL   Acta Crystallogr. F 64:639-640(2008).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.72 ANGSTROMS) IN COMPLEX WITH IMP AND MAGNESIUM
RP   IONS, SUBUNIT, CATALYTIC ACTIVITY, ACTIVITY REGULATION, FUNCTION, AND
RP   COFACTOR.
RX   PubMed=26121039; DOI=10.1371/journal.pone.0131507;
RA   Tresaugues L., Lundbaeck T., Welin M., Flodin S., Nyman T., Silvander C.,
RA   Graeslund S., Nordlund P.;
RT   "Structural basis for the specificity of human NUDT16 and its regulation by
RT   inosine monophosphate.";
RL   PLoS ONE 10:E0131507-E0131507(2015).
RN   [15] {ECO:0007744|PDB:6X7U, ECO:0007744|PDB:6X7V}
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) IN COMPLEX WITH MANGANESE IONS,
RP   FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, AND COFACTOR.
RX   PubMed=32432673; DOI=10.1093/nar/gkaa402;
RA   Sharma S., Grudzien-Nogalska E., Hamilton K., Jiao X., Yang J., Tong L.,
RA   Kiledjian M.;
RT   "Mammalian Nudix proteins cleave nucleotide metabolite caps on RNAs.";
RL   Nucleic Acids Res. 48:6788-6798(2020).
CC   -!- FUNCTION: RNA-binding and decapping enzyme that catalyzes the cleavage
CC       of the cap structure of snoRNAs and mRNAs in a metal-dependent manner.
CC       Part of the U8 snoRNP complex that is required for the accumulation of
CC       mature 5.8S and 28S rRNA. Has diphosphatase activity and removes m7G
CC       and/or m227G caps from U8 snoRNA and leaves a 5'monophosphate on the
CC       RNA. Catalyzes also the cleavage of the cap structure on mRNAs. Does
CC       not hydrolyze cap analog structures like 7-methylguanosine nucleoside
CC       triphosphate (m7GpppG). Also hydrolysis m7G- and m227G U3-capped RNAs
CC       but with less efficiencies. Has broad substrate specificity with
CC       manganese or cobalt as cofactor and can act on various RNA species.
CC       Binds to the U8 snoRNA; metal is not required for RNA-binding. May play
CC       a role in the regulation of snoRNAs and mRNAs degradation. Acts also as
CC       a phosphatase; hydrolyzes the non-canonical purine nucleotides inosine
CC       diphosphate (IDP) and deoxyinosine diphosphate (dITP) as well as
CC       guanosine diphosphate (GDP), deoxyguanosine diphosphate (dGDP),
CC       xanthine diphosphate (XDP), inosine triphosphate (ITP) and deoxyinosine
CC       triphosphate (ITP) to their respective monophosphate derivatives and
CC       does not distinguish between the deoxy- and ribose forms
CC       (PubMed:20385596, PubMed:26121039). The order of activity with
CC       different substrates is IDP > dIDP >> GDP = dGDP > XDP = ITP = dITP
CC       (PubMed:20385596). Binds strongly to GTP, ITP and XTP. Participates in
CC       the hydrolysis of dIDP/IDP and probably excludes non-canonical purines
CC       from RNA and DNA precursor pools, thus preventing their incorporation
CC       into RNA and DNA and avoiding chromosomal lesions (PubMed:20385596).
CC       Exhibits decapping activity towards NAD-capped RNAs and FAD-capped RNAs
CC       (PubMed:32432673). Exhibits decapping activity towards dpCoA-capped
CC       RNAs in vitro (By similarity). {ECO:0000250|UniProtKB:Q6P3D0,
CC       ECO:0000269|PubMed:15053875, ECO:0000269|PubMed:17567574,
CC       ECO:0000269|PubMed:18820299, ECO:0000269|PubMed:20385596,
CC       ECO:0000269|PubMed:21070968, ECO:0000269|PubMed:21337011,
CC       ECO:0000269|PubMed:26121039, ECO:0000269|PubMed:32432673}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 5'-end (N(7)-methyl 5'-triphosphoguanosine)-ribonucleoside
CC         in mRNA + H2O = a 5'-end phospho-ribonucleoside in mRNA + 2 H(+) +
CC         N(7)-methyl-GDP; Xref=Rhea:RHEA:67484, Rhea:RHEA-COMP:15692,
CC         Rhea:RHEA-COMP:17167, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:63714, ChEBI:CHEBI:138282, ChEBI:CHEBI:156461;
CC         EC=3.6.1.62; Evidence={ECO:0000269|PubMed:15053875,
CC         ECO:0000269|PubMed:17567574, ECO:0000269|PubMed:18820299,
CC         ECO:0000269|PubMed:21070968, ECO:0000269|PubMed:21337011};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67485;
CC         Evidence={ECO:0000269|PubMed:15053875, ECO:0000269|PubMed:17567574,
CC         ECO:0000269|PubMed:18820299, ECO:0000269|PubMed:21070968,
CC         ECO:0000269|PubMed:21337011};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + IDP = H(+) + IMP + phosphate; Xref=Rhea:RHEA:35207,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:58053, ChEBI:CHEBI:58280; EC=3.6.1.64;
CC         Evidence={ECO:0000269|PubMed:20385596, ECO:0000269|PubMed:26121039};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35208;
CC         Evidence={ECO:0000269|PubMed:20385596, ECO:0000269|PubMed:26121039};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dIDP + H2O = dIMP + H(+) + phosphate; Xref=Rhea:RHEA:35211,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:61194, ChEBI:CHEBI:62286; EC=3.6.1.64;
CC         Evidence={ECO:0000269|PubMed:20385596, ECO:0000269|PubMed:26121039};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35212;
CC         Evidence={ECO:0000269|PubMed:20385596, ECO:0000269|PubMed:26121039};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 5'-end NAD(+)-phospho-ribonucleoside in mRNA + H2O = a 5'-
CC         end phospho-adenosine-phospho-ribonucleoside in mRNA + beta-
CC         nicotinamide D-ribonucleotide + 2 H(+); Xref=Rhea:RHEA:60876,
CC         Rhea:RHEA-COMP:15698, Rhea:RHEA-COMP:15719, ChEBI:CHEBI:14649,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:144029,
CC         ChEBI:CHEBI:144051; Evidence={ECO:0000269|PubMed:32432673};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60877;
CC         Evidence={ECO:0000269|PubMed:32432673};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 5'-end FAD-phospho-ribonucleoside in mRNA + H2O = a 5'-end
CC         phospho-adenosine-phospho-ribonucleoside in mRNA + FMN + 2 H(+);
CC         Xref=Rhea:RHEA:67588, Rhea:RHEA-COMP:15719, Rhea:RHEA-COMP:17275,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:144051, ChEBI:CHEBI:172372;
CC         Evidence={ECO:0000269|PubMed:32432673};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67589;
CC         Evidence={ECO:0000305|PubMed:32432673};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 5'-end CoA-ribonucleoside in mRNA + H2O = (R)-4'-
CC         phosphopantetheine + a 5'-end phospho-adenosine-phospho-
CC         ribonucleoside in mRNA + 2 H(+); Xref=Rhea:RHEA:67592, Rhea:RHEA-
CC         COMP:15719, Rhea:RHEA-COMP:17276, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:61723, ChEBI:CHEBI:144051,
CC         ChEBI:CHEBI:172371; Evidence={ECO:0000250|UniProtKB:Q6P3D0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67593;
CC         Evidence={ECO:0000250|UniProtKB:Q6P3D0};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:17567574, ECO:0000269|PubMed:21337011,
CC         ECO:0000269|PubMed:26121039};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:17567574, ECO:0000269|PubMed:21337011,
CC         ECO:0000269|PubMed:32432673};
CC       Name=Co(2+); Xref=ChEBI:CHEBI:48828;
CC         Evidence={ECO:0000269|PubMed:17567574, ECO:0000269|PubMed:21337011};
CC       Note=Binds 3 or 4 divalent metal cations. Acts specifically on U8
CC       snoRNA with magnesium as cofactor. Has broad substrate specificity with
CC       bound manganese or cobalt (in vitro). {ECO:0000269|PubMed:17567574,
CC       ECO:0000269|PubMed:21337011};
CC   -!- ACTIVITY REGULATION: The phosphatase activity is inhibited by the
CC       product IMP. {ECO:0000269|PubMed:26121039}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.062 uM for IDP (at 37 degrees Celsius)
CC         {ECO:0000269|PubMed:20385596};
CC         KM=0.088 uM for dIDP (at 37 degrees Celsius)
CC         {ECO:0000269|PubMed:20385596};
CC         KM=0.330 uM for GDP (at 37 degrees Celsius)
CC         {ECO:0000269|PubMed:20385596};
CC         KM=0.319 mM for dGDP (at 37 degrees Celsius)
CC         {ECO:0000269|PubMed:20385596};
CC         KM=15.7 mM for XDP (at 37 degrees Celsius)
CC         {ECO:0000269|PubMed:20385596};
CC         KM=22.1 mM for ITP (at 37 degrees Celsius)
CC         {ECO:0000269|PubMed:20385596};
CC         KM=24.1 mM for dITP (at 37 degrees Celsius)
CC         {ECO:0000269|PubMed:20385596};
CC         Note=kcat is 0.931 sec(-1) with IDP. kcat is 0.966 sec(-1) with dIDP.
CC         kcat is 0.518 sec(-1) with GDP. kcat is 0.492 sec(-1) with dGDP. kcat
CC         is 2.6 sec(-1) with XDP. kcat is 3.06 sec(-1) with ITP. kcat is 3.2
CC         sec(-1) with dITP. The catalytic efficiency for IDP is at least 1.3-
CC         fold higher than for dIDP, 9.6-fold higher than for GDP and dGDP,
CC         100-fold higher than for XDP, ITP and dITP.
CC         {ECO:0000269|PubMed:20385596};
CC       pH dependence:
CC         Gradually increased from pH 6.5 to 8.5 in its IDP hydrolyzing
CC         activity. {ECO:0000269|PubMed:20385596};
CC       Temperature dependence:
CC         Exhibited a temperature-dependent increase in its IDP hydrolyzing
CC         activity up to 60 degrees Celsius. {ECO:0000269|PubMed:20385596};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:17567574,
CC       ECO:0000269|PubMed:18820299, ECO:0000269|PubMed:26121039,
CC       ECO:0000269|PubMed:32432673}.
CC   -!- INTERACTION:
CC       Q96DE0; Q96DE0: NUDT16; NbExp=2; IntAct=EBI-5464685, EBI-5464685;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20385596,
CC       ECO:0000269|PubMed:21337011}. Nucleus, nucleoplasm
CC       {ECO:0000250|UniProtKB:Q6TEC1}. Nucleus, nucleolus
CC       {ECO:0000250|UniProtKB:Q6TEC1}. Cytoplasm {ECO:0000269|PubMed:21070968,
CC       ECO:0000269|PubMed:21337011}. Note=Localized predominantly in the
CC       cytoplasm (PubMed:21070968). Localized in nucleolus, and in a minor
CC       proportion in distinct foci in the nucleoplasm (By similarity).
CC       {ECO:0000250|UniProtKB:Q6TEC1, ECO:0000269|PubMed:21070968}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q96DE0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96DE0-2; Sequence=VSP_045450, VSP_045451;
CC       Name=3;
CC         IsoId=Q96DE0-3; Sequence=VSP_045449, VSP_045452;
CC       Name=4;
CC         IsoId=Q96DE0-4; Sequence=VSP_045451;
CC   -!- TISSUE SPECIFICITY: Expressed strongly in lung, kidney, adrenal gland,
CC       testis, heart and brain. {ECO:0000269|PubMed:20385596}.
CC   -!- SIMILARITY: Belongs to the Nudix hydrolase family. NUDT16 subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB71024.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK055827; BAB71024.1; ALT_INIT; mRNA.
DR   EMBL; AK304650; BAG65426.1; -; mRNA.
DR   EMBL; BP199028; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC010210; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC009546; AAH09546.1; -; mRNA.
DR   EMBL; BC031215; AAH31215.2; -; mRNA.
DR   CCDS; CCDS3070.2; -. [Q96DE0-1]
DR   CCDS; CCDS54640.1; -. [Q96DE0-4]
DR   CCDS; CCDS54641.1; -. [Q96DE0-3]
DR   RefSeq; NP_001165376.1; NM_001171905.1. [Q96DE0-3]
DR   RefSeq; NP_001165377.1; NM_001171906.1. [Q96DE0-4]
DR   RefSeq; NP_689608.2; NM_152395.2. [Q96DE0-1]
DR   PDB; 2XSQ; X-ray; 1.72 A; A=1-195.
DR   PDB; 3COU; X-ray; 1.80 A; A=1-195.
DR   PDB; 3MGM; X-ray; 1.80 A; A/B=1-195.
DR   PDB; 5VY2; X-ray; 2.30 A; A/B=1-195.
DR   PDB; 5W6X; X-ray; 2.10 A; A/B=1-195.
DR   PDB; 5W6Z; X-ray; 2.61 A; A/B/D/E=1-195.
DR   PDB; 5WJI; X-ray; 2.30 A; A/B=1-195.
DR   PDB; 6B09; X-ray; 3.20 A; A/B=1-195.
DR   PDB; 6CO2; X-ray; 2.49 A; A/B=1-195.
DR   PDB; 6X7U; X-ray; 2.70 A; A/C=1-184.
DR   PDB; 6X7V; X-ray; 2.30 A; A/B/C/D=1-195.
DR   PDBsum; 2XSQ; -.
DR   PDBsum; 3COU; -.
DR   PDBsum; 3MGM; -.
DR   PDBsum; 5VY2; -.
DR   PDBsum; 5W6X; -.
DR   PDBsum; 5W6Z; -.
DR   PDBsum; 5WJI; -.
DR   PDBsum; 6B09; -.
DR   PDBsum; 6CO2; -.
DR   PDBsum; 6X7U; -.
DR   PDBsum; 6X7V; -.
DR   AlphaFoldDB; Q96DE0; -.
DR   SMR; Q96DE0; -.
DR   BioGRID; 126295; 24.
DR   IntAct; Q96DE0; 3.
DR   MINT; Q96DE0; -.
DR   STRING; 9606.ENSP00000422375; -.
DR   iPTMnet; Q96DE0; -.
DR   PhosphoSitePlus; Q96DE0; -.
DR   BioMuta; NUDT16; -.
DR   DMDM; 68565926; -.
DR   EPD; Q96DE0; -.
DR   jPOST; Q96DE0; -.
DR   MassIVE; Q96DE0; -.
DR   MaxQB; Q96DE0; -.
DR   PaxDb; Q96DE0; -.
DR   PeptideAtlas; Q96DE0; -.
DR   PRIDE; Q96DE0; -.
DR   ProteomicsDB; 19864; -.
DR   ProteomicsDB; 24755; -.
DR   ProteomicsDB; 76283; -. [Q96DE0-1]
DR   TopDownProteomics; Q96DE0-1; -. [Q96DE0-1]
DR   Antibodypedia; 46680; 51 antibodies from 17 providers.
DR   DNASU; 131870; -.
DR   Ensembl; ENST00000502852.1; ENSP00000422375.1; ENSG00000198585.12. [Q96DE0-4]
DR   Ensembl; ENST00000521288.2; ENSP00000429274.2; ENSG00000198585.12. [Q96DE0-1]
DR   Ensembl; ENST00000537561.5; ENSP00000440230.1; ENSG00000198585.12. [Q96DE0-3]
DR   GeneID; 131870; -.
DR   KEGG; hsa:131870; -.
DR   MANE-Select; ENST00000521288.2; ENSP00000429274.2; NM_152395.3; NP_689608.2.
DR   UCSC; uc003eog.3; human. [Q96DE0-1]
DR   CTD; 131870; -.
DR   DisGeNET; 131870; -.
DR   GeneCards; NUDT16; -.
DR   HGNC; HGNC:26442; NUDT16.
DR   HPA; ENSG00000198585; Low tissue specificity.
DR   MIM; 617381; gene.
DR   neXtProt; NX_Q96DE0; -.
DR   OpenTargets; ENSG00000198585; -.
DR   PharmGKB; PA134955224; -.
DR   VEuPathDB; HostDB:ENSG00000198585; -.
DR   eggNOG; ENOG502S20E; Eukaryota.
DR   GeneTree; ENSGT00390000016224; -.
DR   HOGENOM; CLU_110418_1_0_1; -.
DR   InParanoid; Q96DE0; -.
DR   OMA; HVMLYCD; -.
DR   OrthoDB; 1385294at2759; -.
DR   PhylomeDB; Q96DE0; -.
DR   BioCyc; MetaCyc:MON-17869; -.
DR   BRENDA; 3.6.1.62; 2681.
DR   BRENDA; 3.6.1.64; 2681.
DR   PathwayCommons; Q96DE0; -.
DR   Reactome; R-HSA-2393930; Phosphate bond hydrolysis by NUDT proteins.
DR   SignaLink; Q96DE0; -.
DR   BioGRID-ORCS; 131870; 8 hits in 1081 CRISPR screens.
DR   ChiTaRS; NUDT16; human.
DR   EvolutionaryTrace; Q96DE0; -.
DR   GenomeRNAi; 131870; -.
DR   Pharos; Q96DE0; Tbio.
DR   PRO; PR:Q96DE0; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q96DE0; protein.
DR   Bgee; ENSG00000198585; Expressed in tendon of biceps brachii and 179 other tissues.
DR   Genevisible; Q96DE0; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0031404; F:chloride ion binding; IDA:UniProtKB.
DR   GO; GO:0050897; F:cobalt ion binding; IDA:UniProtKB.
DR   GO; GO:0097383; F:dIDP diphosphatase activity; IEA:RHEA.
DR   GO; GO:0035870; F:dITP diphosphatase activity; ISS:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:1990003; F:inosine-diphosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:1901641; F:ITP binding; IDA:UniProtKB.
DR   GO; GO:0050072; F:m7G(5')pppN diphosphatase activity; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0030145; F:manganese ion binding; IDA:UniProtKB.
DR   GO; GO:0008235; F:metalloexopeptidase activity; IDA:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; IDA:UniProtKB.
DR   GO; GO:0098519; F:nucleotide phosphatase activity, acting on free nucleotides; IDA:UniProtKB.
DR   GO; GO:1990174; F:phosphodiesterase decapping endonuclease activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0110153; F:RNA NAD-cap (NMN-forming) hydrolase activity; IEA:RHEA.
DR   GO; GO:0030515; F:snoRNA binding; IDA:UniProtKB.
DR   GO; GO:1901640; F:XTP binding; IDA:UniProtKB.
DR   GO; GO:0006382; P:adenosine to inosine editing; IMP:UniProtKB.
DR   GO; GO:0035863; P:dITP catabolic process; ISS:UniProtKB.
DR   GO; GO:0046709; P:IDP catabolic process; IDA:UniProtKB.
DR   GO; GO:0006402; P:mRNA catabolic process; IDA:UniProtKB.
DR   GO; GO:0110155; P:NAD-cap decapping; IDA:UniProtKB.
DR   GO; GO:2000233; P:negative regulation of rRNA processing; ISS:UniProtKB.
DR   GO; GO:0090068; P:positive regulation of cell cycle process; IMP:UniProtKB.
DR   GO; GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; IDA:UniProtKB.
DR   GO; GO:0016077; P:sno(s)RNA catabolic process; IDA:UniProtKB.
DR   InterPro; IPR015797; NUDIX_hydrolase-like_dom_sf.
DR   InterPro; IPR000086; NUDIX_hydrolase_dom.
DR   Pfam; PF00293; NUDIX; 1.
DR   SUPFAM; SSF55811; SSF55811; 1.
DR   PROSITE; PS51462; NUDIX; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; Hydrolase; Magnesium;
KW   Manganese; Metal-binding; Nucleotide metabolism; Nucleotide-binding;
KW   Nucleus; Reference proteome; RNA-binding.
FT   CHAIN           1..195
FT                   /note="U8 snoRNA-decapping enzyme"
FT                   /id="PRO_0000057117"
FT   DOMAIN          18..173
FT                   /note="Nudix hydrolase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00794"
FT   MOTIF           61..82
FT                   /note="Nudix box"
FT   BINDING         24
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000305|PubMed:26121039"
FT   BINDING         50
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000305|PubMed:26121039"
FT   BINDING         57
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000305|PubMed:26121039"
FT   BINDING         59
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:32432673,
FT                   ECO:0000305|PubMed:26121039, ECO:0007744|PDB:6X7U"
FT   BINDING         76
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000305|PubMed:26121039"
FT   BINDING         76
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:Q6TEC1"
FT   BINDING         80
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:32432673,
FT                   ECO:0000305|PubMed:26121039, ECO:0007744|PDB:6X7U"
FT   BINDING         80
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:Q6TEC1"
FT   BINDING         99
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000269|PubMed:32432673,
FT                   ECO:0007744|PDB:6X7U, ECO:0007744|PDB:6X7V"
FT   BINDING         170
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000305|PubMed:26121039"
FT   BINDING         173
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000269|PubMed:32432673,
FT                   ECO:0007744|PDB:6X7U, ECO:0007744|PDB:6X7V"
FT   VAR_SEQ         1..46
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16344560"
FT                   /id="VSP_045449"
FT   VAR_SEQ         1..33
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045450"
FT   VAR_SEQ         138..195
FT                   /note="LGLVRVPLYTLRDGVGGLPTFLENSFIGSAREQLLEALQDLGLLQSGSISGL
FT                   KIPAHH -> GPAWDSVPFPISSSPKAFSPPRKHPWRKVFAPLTLPSPQLSWWSWDRDH
FT                   LYSELVLPTWAFCKGLSHPLPGEILSRTHSSMSLCCSLLTV (in isoform 2 and
FT                   isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045451"
FT   VAR_SEQ         174..195
FT                   /note="ALQDLGLLQSGSISGLKIPAHH -> AALHGPMKTEMRTLVLGREGRTWECF
FT                   LIGSER (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16344560"
FT                   /id="VSP_045452"
FT   CONFLICT        22
FT                   /note="A -> V (in Ref. 4; AAH31215)"
FT                   /evidence="ECO:0000305"
FT   STRAND          5..7
FT                   /evidence="ECO:0007829|PDB:2XSQ"
FT   HELIX           9..13
FT                   /evidence="ECO:0007829|PDB:2XSQ"
FT   STRAND          20..35
FT                   /evidence="ECO:0007829|PDB:2XSQ"
FT   TURN            36..38
FT                   /evidence="ECO:0007829|PDB:2XSQ"
FT   STRAND          39..50
FT                   /evidence="ECO:0007829|PDB:2XSQ"
FT   STRAND          58..61
FT                   /evidence="ECO:0007829|PDB:2XSQ"
FT   TURN            64..66
FT                   /evidence="ECO:0007829|PDB:3MGM"
FT   HELIX           69..81
FT                   /evidence="ECO:0007829|PDB:2XSQ"
FT   HELIX           83..87
FT                   /evidence="ECO:0007829|PDB:2XSQ"
FT   HELIX           92..94
FT                   /evidence="ECO:0007829|PDB:2XSQ"
FT   STRAND          95..100
FT                   /evidence="ECO:0007829|PDB:2XSQ"
FT   STRAND          102..114
FT                   /evidence="ECO:0007829|PDB:2XSQ"
FT   HELIX           117..126
FT                   /evidence="ECO:0007829|PDB:2XSQ"
FT   HELIX           127..129
FT                   /evidence="ECO:0007829|PDB:2XSQ"
FT   TURN            134..136
FT                   /evidence="ECO:0007829|PDB:2XSQ"
FT   STRAND          137..142
FT                   /evidence="ECO:0007829|PDB:2XSQ"
FT   STRAND          149..152
FT                   /evidence="ECO:0007829|PDB:6B09"
FT   HELIX           155..158
FT                   /evidence="ECO:0007829|PDB:2XSQ"
FT   HELIX           167..177
FT                   /evidence="ECO:0007829|PDB:2XSQ"
FT   TURN            178..181
FT                   /evidence="ECO:0007829|PDB:2XSQ"
FT   CONFLICT        Q96DE0-3:128
FT                   /note="Missing (in Ref. 2; BP199028)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   195 AA;  21273 MW;  4AC7EA679D1D7468 CRC64;
     MAGARRLELG EALALGSGWR HACHALLYAP DPGMLFGRIP LRYAILMQMR FDGRLGFPGG
     FVDTQDRSLE DGLNRELREE LGEAAAAFRV ERTDYRSSHV GSGPRVVAHF YAKRLTLEEL
     LAVEAGATRA KDHGLEVLGL VRVPLYTLRD GVGGLPTFLE NSFIGSAREQ LLEALQDLGL
     LQSGSISGLK IPAHH
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024